PROCEPT BioRobotics (PRCT) Shares Outstanding (Weighted Average) (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Shares Outstanding (Weighted Average) data on file, last reported at $56.5 million in Q1 2026.

• Quarterly Shares Outstanding (Weighted Average) rose 2.9% year-over-year to $56.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $56.5 million (up 2.9% YoY) and the FY2025 annual result came in at $55.5 million, up 6.56% from the prior year.
• Shares Outstanding (Weighted Average) rose to $56.5 million in Q1 2026 per PRCT's latest filing, from $55.5 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $56.5 million in Q1 2026 and bottomed at $43.9 million in Q1 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $51.0 million (2024), against an average of $49.8 million.
• The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) jumped 807.97%; it then advanced 1.58% in 2023.
• Tracing PRCT's Shares Outstanding (Weighted Average) over 5 years: stood at $44.4 million in 2022, then climbed by 6.43% to $47.3 million in 2023, then increased by 10.31% to $52.1 million in 2024, then increased by 6.56% to $55.5 million in 2025, then grew by 1.74% to $56.5 million in 2026.
• Per Business Quant, the three latest PRCT Shares Outstanding (Weighted Average) figures stand at $56.5 million (Q1 2026), $55.5 million (Q4 2025), and $55.4 million (Q3 2025).

Peer Comparison